TriLink has been an industry leader in synthesizing high quality oligonucleotides for research, diagnostics, therapeutics, and OEM for more than 20 years. We offer a wide selection of DNA, …

1 day ago · SAN DIEGO, February 03, 2025--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and …

TriLink BioTechnologies, part of Maravai LifeSciences, is a best-in-class contract development and manufacturing organization (CDMO) for the synthesis of nucleic acids, NTPs and mRNA …

1 day ago · TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative nucleic acid products to customers …

1 day ago · TriLink partners with Avantor to enhance European access to nucleic acid products, streamlining ordering and reducing lead times for CleanCap® and mRNA solutions.

Leverage a legacy of trailblazing innovation in your mRNA research and discovery with TriLink. Our dedicated staff has specialized mRNA expertise to support your journey, helping you …

May 13, 2024 · A new center within the Johns Hopkins Whiting School of Engineering will accelerate research and therapeutic development, leveraging TriLink’s leading RNA synthesis …

TriLink delivers unrivaled chemical and biological experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap® mRNA capping technology.

Apr 18, 2024 · The 32,000-square-foot facility was specifically designed for mRNA manufacturing to support late-phase drug developers from Phase 2 to commercialization via TriLink’s robust …

Apr 18, 2024 · TriLink BioTechnologies (TriLink ®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand …